Maxime Dely: Venous Access in Apheresis Technology Isn’t Everything
Maxime Dely, Therapeutic Solutions Sales Consultant at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
”Venous access in apheresis technology isn’t everything
In apheresis, the objective is clear: collect blood, process it, and isolate either harmful elements or useful components such as specific lymphocyte subsets
But behind this technical process lies a very concrete reality: venous access
Without a usable vein, there is no apheresis. And depending on the patient’s condition – disease, malnutrition, or vascular fragility – access can be a real challenge
Another key factor is flow rate. It must be sufficient to feed the centrifuge, but it also directly impacts the duration of the procedure and therefore the patient’s comfort
Solutions exist such as vascular mapping, Doppler, and ultrasound. But they don’t replace what matters most
Nursing expertise
Their experience often makes all the difference where technology alone falls short
Because beyond the machines, there is an essential human factor
What role do you think hands-on expertise should play alongside technology?”
Stay updated with Hemostasis Today.
-
Apr 24, 2026, 16:56Nazish Saqlain: Hands-on Training Workshop in Transfusion Medicine and Immunohematology
-
Apr 24, 2026, 16:49Michael Greger: Most Heart Attacks Are Triggered by Non-Obstructive Plaques
-
Apr 24, 2026, 15:12Jim Hoffman: Linking Post-Acute Chronic Infection Brain Injury and Autoimmune Dysregulation
-
Apr 24, 2026, 15:11Ensuring That Science Translates Into Real Impact for Patients – EAHAD
-
Apr 24, 2026, 15:09Batool Abuhalimeh: Why Integrating Sex And Gender Into Vascular Care Is No Longer Optional, It’s Essential
-
Apr 24, 2026, 15:08Luke McLaughlin: Publishing First Article on Haemophilia Rights
-
Apr 24, 2026, 15:06Cathy Harrison: Strengthening Global Care Networks – Insights from WFH Congress 2026
-
Apr 24, 2026, 14:29Brian O Mahony: Clinical Management of Emicizumab and Rebalancing Agents
-
Apr 24, 2026, 14:10Abel Sandmann։ How Common Are Cerebral Cavernous Malformations, Actually?